ABMD Financial Facts

Funded research and development: 6K
Revenues, Total: 85.8M
See Full Income Statement

Treasury stock at cost - 50,954 shares: -26.66M
Prepaid expenses and other current assets: 6.78M
See Full Balance Sheet

Abiomed Inc. (ABMD) Earnings

  |   Expand Research on ABMD
Next EPS Date 8/4/16 *Est. EPS Growth Rate -89.3% *Last Qtr.
Average EPS % Beat Rate +432.4% Revenue Growth Rate +39.1% *Last Qtr.
Average % Move 1-Wk after EPS +2.0% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/3/16 Q416 $0.24$0.19 +$0.05$94M$90.52M N/A Details
2/4/16 Q316 $0.23$0.15 +$0.08$85.8M$80.04M N/A Details
8/4/15 Q116 $0.20$0.08 +$0.12$73.4M$66.27M N/A Details
5/5/15 Q415 $2.24$0.14 +$2.10$67.6M$62.55M N/A Details
1/28/15 Q315 $0.30$0.04 +$0.26$62M$53.2M Details
10/30/14 Q215 $0.03$0.02 +$0.01$51.8M$48.8M Details
7/31/14 Q115 -$0.04N/A N/A $48.8M$297.1M Details
5/1/14 Q414 $0.09$0.08 +$0.01$50.4M$50.93M Details